Norway Brings DNA Sequencing To National Healthcare
ananyo writes "Norway is set to become the first country to incorporate genome sequencing into its national health-care system. The Scandinavian nation, which has a population of 4.8 million, will use 'next-generation' DNA sequencers to trawl for mutations in tumors that might reveal which cancer treatments would be most effective. In its three-year pilot phase, the Norwegian Cancer Genomics Consortium will sequence the tumor genomes of 1,000 patients in the hope of influencing their treatments. It will also look at another 3,000 previously obtained tumor biopsies to get a better idea of the mutations in different cancers, and how they influence a patient's response to a drug. In a second phase, the project will build the laboratory, clinical and computing infrastructure needed to bring such care to the 25,000 Norwegians who are diagnosed with cancer each year. Similar projects are under way in the United Kingdom and at research hospitals in the United States, France and elsewhere. But Norway's will be among the first to look for tumor mutations using next-generation DNA sequencing rather than conventional genetic testing."
I'm not sure with current technology this will be very useful. Better than nothing? As I have said in the past, http://slashdot.org/comments.pl?sid=1408231&cid=29781469 -this is the way forward .. but I hope it's not at the expense of long term. I mean look how long it is taking for us to wean of incandescent lightbulbs and gasoline.
We really need a way to do long reads, coupled with single cell sequencing technology. That's the proper way to attack cancer. Hmm, also we may need a way to find out chromatin structure on a single cell basis too. Get on it.
It's sad to think that we can't do these kinds of massive human genome sequencing projects in America. Anybody who got their DNA sequenced would be at immediate risk of losing their healthcare or seeing their premiums triple.
I write science part-time for the University of Colorado Cancer Center -- biomarkers are totally the way of the future. In lung cancer, we discovered that a ALK-EML4 gene rearrangement predicts great response to the drug crizotinib; we know about PSA in prostate cancer; we test for hormone dependence in breast cancer. Hopefully the Norway sequencing will add to this list of biomarkers that allow us to find cancer early and give doctors clues to its treatment. (Now, the next-gen is *protein* sequencing.)
GeekDad, TED speaker, Wipeout loser, author of Brain Trust